Skip to Content

a15 (Rinvoq 15 mg)

Generic Name: upadacitinib

Pill with imprint a15 is Purple, Capsule-shape and has been identified as Rinvoq 15 mg. It is supplied by AbbVie Inc..

Rinvoq is used in the treatment of rheumatoid arthritis and belongs to the drug class antirheumatics. Rinvoq 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for a15

Rinvoq 15 mg a15

Rinvoq

Generic Name
upadacitinib
Imprint
a15
Strength
15 mg
Color
Purple
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antirheumatics
CSA Schedule
Not a controlled drug
Labeler / Supplier
AbbVie Inc.
National Drug Code (NDC)
00074-2306

Get help with Imprint Code FAQs.

Related Images for "a15"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.